These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20676640)

  • 21. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
    Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A
    J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents.
    Jones GL; Taylor PR; Windebank KP; Hoye NA; Lucraft H; Wood K; Angus B; Proctor SJ
    Br J Cancer; 2007 Jul; 97(1):29-36. PubMed ID: 17533403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
    Sun HL; Atenafu EG; Tsang R; Kukreti V; Marras TK; Crump M; Kuruvilla J
    Leuk Lymphoma; 2017 Nov; 58(11):2607-2614. PubMed ID: 28504035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
    Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G
    Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of favorable early-stage hodgkin's lymphoma treatments: a single-institution review.
    Samant R; Alomary I; Alsaeed E; Al-Jasir B; Bence-Bruckler I; Cross P; Genest P; Huebsch L
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1166-70. PubMed ID: 19695788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
    Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
    Diehl V; Fuchs M;
    Transfus Apher Sci; 2007 Aug; 37(1):37-41. PubMed ID: 17714996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma.
    Falay O; Öztürk E; Bölükbaşı Y; Gümüş T; Örnek S; Özbalak M; Çetiner M; Demirkol O; Ferhanoğlu B
    Leuk Lymphoma; 2017 May; 58(5):1114-1122. PubMed ID: 28185527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis.
    Frusch N; Servais S; De Prijck B; Corhay JL; Beguin Y; Louis R; Duysinx B
    Acta Clin Belg; 2012; 67(5):370-1. PubMed ID: 23189547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
    Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleomycin-induced pneumonitis in three patients treated with chemotherapy for primary advanced seminoma.
    Stein ME; Zidan J; Charas T; Gershuny A; Ben-Yosef R
    J BUON; 2015; 20(3):928-32. PubMed ID: 26214649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis.
    Kirsch J; Arrossi AV; Yoon JK; Wu G; Neumann DR
    J Thorac Imaging; 2006 Aug; 21(3):228-30. PubMed ID: 16915070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma.
    Al-Jizani WA; Al-Mansour MM; Al-Fayea TM; Shafi RU; Kazkaz GA; Bayer AM; Al-Foheidi ME; Ibrahim EM
    Future Oncol; 2015; 11(15):2149-57. PubMed ID: 26235180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleomycin-induced pneumonitis.
    Sleijfer S
    Chest; 2001 Aug; 120(2):617-24. PubMed ID: 11502668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of pulmonary toxicity of bleomycin and filgrastim.
    Laprise-Lachance M; Lemieux P; Grégoire JP
    J Oncol Pharm Pract; 2019 Oct; 25(7):1638-1644. PubMed ID: 30319063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor
    Andersen MD; Kamper P; d'Amore A; Clausen M; Bentzen H; d'Amore F
    Leuk Lymphoma; 2019 Apr; 60(4):927-933. PubMed ID: 30277120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural course of bleomycin-induced pneumonitis. A follow-up study.
    Van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Koops HS; Sluiter HJ; Peset R
    Am Rev Respir Dis; 1987 Jan; 135(1):48-51. PubMed ID: 2432813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.